Role of feed-regulating peptides on pancreatic exocrine secretion

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL.2, 2008, Pages 145-159

  Kapica, Małgorzata ^a   Puzio, I ^a   Kato, I ^b   Kuwahara, A ^c   Zabielski, R ^d  

^a UNIVERSITY OF LIFE SCIENCES IN LUBLIN   (Poland)

^b HOKURIKU UNIVERSITY   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

^d WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

Author keywords

Apelin; Ghrelin; Leptin; Obestatin; Orexins

Indexed keywords

APELIN; GHRELIN; INSULIN; LEPTIN; OBESTATIN; OREXIN; OREXIN A; OREXIN B; PEPTIDE DERIVATIVE;

BODY MASS; CONFERENCE PAPER; ENERGY METABOLISM; ENTEROENDOCRINE CELL; FOOD INTAKE; HORMONE ACTION; HUMAN; INSULIN RELEASE; NONHUMAN; PANCREAS FUNCTION; PANCREAS JUICE; PANCREAS SECRETION; PEPTIDE ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE DISTRIBUTION;

ANIMALS; GHRELIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LEPTIN; NEUROPEPTIDES; PANCREAS, EXOCRINE; PANCREATIC JUICE; RATS; RECEPTOR, CHOLECYSTOKININ A; VAGUS NERVE;

EID: 51449111911     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (109)

1. Zhang Y, Proenca R, Maffei M, Barone M, Leopold I, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432.
2. Matyjek R, Kapica M, Puzio I, Babelewska M, Zabielski R. The effect of fundectomy on pancreatic secretion in anaesthetized rats J Physiol Pharmacol 2004; 55 Suppl. 2; 69-75.
3. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998; 394: 790-793.
4. Sinha MK, Opentanova I, Ohannesian JP, et al. Evidence of free and bound leptin in human circulation. Studies in lean and obese subjects and during short-term fasting. J Clin Invest 1996; 98: 1277-1282.
5. Sobhani I, Bado A, Vissuzaine C, et al. Leptin secretion and leptin receptor in the human stomach. Gut 2000; 47: 178-183.
6. Mix H, Widjaja A, Jandl O, et al. Expression of leptin and leptin receptor isoforms in the human stomach. Gut 2000; 47: 481-486.
7. Morton NM, Emilsson V, Liu YL, Cawthorne MA. Leptin action in intestinal cells. J Biol Chem 1998; 273: 26194-26201.
8. Lostao MP, Urdaneta E, Martinez-Anso E, Barber A, Martinez JA. Presence of leptin receptors in rat small intestine and leptin effect on sugar absorption. FEBS Lett 1998; 423: 302-306.
9. Kieffer TJ, Heller RS, Habener JF. Leptin receptors expressed on pancreatic beta-cells. Biochem Biophys Res Commun 1996; 224: 522-527.
10. Harris DM, Flannigan KL, Go VL, Wu SV. Regulation of cholecystokinin- mediated amylase secretion by leptin in rat pancreatic acinar tumor cell line AR42J. Pancreas 1999; 19: 224-230.
11. Jaworek J, Bonior J, Leja-Szpak A, et al. Sensory nerves in central and peripheral control of pancreatic integrity by leptin and melatonin. J Physiol Pharmacol 2002; 53: 51-74.
12. Konturek SJ, Konturek JW. Cephalic phase of pancreatic secretion. Appetite 2000; 34: 197-205.
13. Guilmeau S, Nagain-Domaine C, Buysse M, Tsocas A, Roze C, Bado A. Modulation of exocrine pancreatic secretion by leptin through CCK1-receptors and afferent vagal fibres in the rat. Eur J Pharmacol 2002; 447: 99-107.
14. Matyjek R, Herzig KH, Kato S, Zabielski R. Exogenous leptin inhibits the secretion of pancreatic juice via a duodenal CCK1-vagal-dependent mechanism in anaesthetized rats. Regul Pept 2003; 114: 15-20.
15. Brzozowski T, Konturek PC, Konturek SJ, et al. Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide. Eur J Pharmacol 1999; 74: 263-276.
16. Yuan CS, Attele AS, Wu JA, Zhang L, Shi ZQ. Peripheral gastric leptin modulates brain stem neuronal activity in neonates. Am J Physiol 1999; 277: G626-G660.
17. Seufert J, Kieffer TJ, Habener JF. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob/ob mice. Proc Natl Acad Sci USA 1999; 96: 674-679.
18. Kulkarni RN, Wang ZL, Wang RM, et al. Leptin rapidly suppresses insulin release from insulinoma cells, rat and human islets and, in vivo, in mice. J Clin Invest 1997; 100: 2729-2736.
19. Fehmann HC, Berghofer P, Brandhorst D, et al. Leptin inhibition of insulin secretion from isolated human islets. Acta Diabetol 1997; 34: 249-252.
20. Poitout V, Rouault C, Guerre-Millo M, Briaud I, Reach G. Inhibition of insulin secretion by leptin in normal rodent islets of Langerhans. Endocrinology 1998; 139: 822-826.
21. Ariyasu H, Takaya K, Tagami T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab 2001; 86: 4753-4758.
22. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing peptide from stomach. Nature 1999; 402: 656-660.
23. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000; 279: 909-913.
24. Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology 2000; 141: 4255-4261.
25. Mori K, Yoshimoto A, Takaya K, et al. Kidney produces a novel acylated peptide, ghrelin. FEBS Lett 2000; 486: 213-216.
26. Gualillo O, Caminos J, Blanco M, et al. Ghrelin, a novel placental-derived hormone. Endocrinology 2001; 142: 788-794.
27. Tanaka M, Hayashida Y, Nakao N, Nakai N, Nakashima K. Testis-specific and developmentally induced expression of a ghrelin gene-derived transcript that encodes a novel polypeptide in the mouse. Biochim Biophys Acta 2001; 1522: 62-65.
28. Date Y, Nakazato M, Hashiguchi S, et al. Ghrelin is present in pancreatic alpha-cells of humans and rats and stimulates insulin secretion. Diabetes 2002; 51: 124-129.
29. Gnanapavan S, Kola B, Bustin SA, et al. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 2002; 87: 2988-2991.
30. Hattori N, Saito T, Yagyu T, Jiang BH, Kitagawa K, Inagaki C. GH, GH receptor, GH secretagogue receptor, and ghrelin expression in human T cells, B cells, and neutrophils. J Clin Endocrinol Metab 2001; 86: 4284-4291.
31. Muccioli G, Tschop M, Papotti M, Deghenghi R, Heiman M, Ghigo E. Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity. Eur J Pharmacol 2002; 440: 235-254.
32. Tena-Sempere M, Barreiro ML, Gonzalez LC, et al. Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002; 143: 717-725.
33. Volante M, Allia E, Gugliotta P, et al. Expression of ghrelin and of the GH secretagogue receptor by pancreatic islet cells and related endocrine tumors. J Clin Endocrinol Metab 2002; 87: 1300-1308.
34. Volante M, Fulcheri E, Allia E, Cerrato M, Pucci A, Papotti M. Ghrelin expression in fetal, infant, and adult human lung. J HistochemCytochem 2002; 50: 1013-1021.
35. Kamegai J, Tamura H, Shimizu T, Ishii S, Sugihara H, Wakabayashi I. Chronic central infusion of ghrelin increases hypothalamic neuropeptide Yand Agouti-related protein mRNA levels and body weight in rats. Diabetes 2001; 50: 2438-2443.
36. Nakazato M, Murakami N, Date Y, et al. A role for ghrelin in the central regulation of feeding. Nature 2001; 409: 194-198.
37. Shintani M, Ogawa Y, Ebihara K, et al. Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 2001; 50: 227-232.
38. Wren AM, Small CJ, Abbott CR, et al. Ghrelin causes hyperphagia and obesity in rats. Diabetes 2001; 50: 2540-2547.
39. Wren AM, Seal LJ, Cohen MA, Brynes AE, Frost GS, Murphy KG. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab 2001; 86: 5992-5995.
40. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002; 346: 1623-1630.
41. Cummings DE, Overduin J. Gastrointestinal regulation of food intake. J Clin Invest 2007; 117: 13-23.
42. Wierup N, Svensson H, Mulder H, Sundler F. The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas. Regul Pept 2002; 107: 63-69.
43. 2+ signaling in β-cells: implication in the glycemic control in rodents. Diabetes 2004; 53: 3142-3151.
44. Prado CL, Pugh-Bernard AE, Elghazi L, Sosa-Pineda B, Sussel L. Ghrelin cells replace insulin-producing β cells in two mouse models of pancreas development. Proc Natl Acad Sci U S A 2004; 101: 2924-2929.
45. Wierup N, Yang S, McEvilly RJ, Mulder H, Sundler F. Ghrelin is expressed in a novel endocrine cell type in developing rat islets and inhibits insulin secretion from INS-1 (832/13) cells. J Histochem Cytochem 2004; 52: 301-310.
46. Wierup N, Sundler F. Ultrastructure of islet ghrelin cells in the human fetus. Cell Tissue Res 2005; 319: 423-428.
47. Ikezaki A, Hosoda H, Ito K, et al. Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 2002; 51: 3408-3411.
48. Poykko SM, Kellokoski E, Horkko S, Kauma H, Kesaniemi YA, Ukkola O. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 2003; 52: 2546-2553.
49. Tschop M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709.
50. Ariyasu H, Takaya K, Hosoda H, et al. Delayed short-term secretory regulation of ghrelin in obese animals: evidenced by a specific RIA for the active form of ghrelin. Endocrinology 2002; 143: 3341-3350.
51. Shiiya T, Nakazato M, Mizuta M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab 2002; 87: 240-244.
52. Reimer MK, Pacini G, Ahren B. Dose-dependent inhibition by ghrelin of insulin secretion in the mouse. Endocrinology 2003; 144: 916-921.
53. Colombo M, Gregersen S, Xiao J, Hermansen K. Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas 2003; 27: 161-166.
54. 2+ signaling in beta-cells: implication in the glycemic control in rodents. Diabetes 2004; 53: 3142-3151.
55. Adeghate E, Ponery AS. Ghrelin stimulates insulin secretion from the pancreas of normal and diabetic rats. J Neuroendocrinol 2002; 14: 555-560.
56. Egido EM, Rodriguez-Gallardo J, Silvestre RA, Marco J. Inhibitory effect of ghrelin on insulin and pancreatic somatostatin secretion. Eur J Endocrinol 2002; 146: 241-244.
57. Lee HM, Wang G, Englander EW, Kojima M, Greeley GH. Ghrelin, a new gastrointestinal endocrine peptide that stimulates insulin secretion: enteric distribution, ontogeny, influence of endocrine, and dietary manipulations. Endocrinology 2002; 143: 185-190.
58. Broglio F, Arvat E, Benso A, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. J Clin Endocrinol Metab 2001; 86: 5083-5086.
59. Broglio F, Arvat E, Benso A, et al. Endocrine activities of cortistatin-14 and its interaction with GHRH and ghrelin in humans. J Clin Endocrinol Metab 2002; 87: 3783-3790.
60. Hosoda H, Kojima M, Matsuo H, Kangawa K. Ghrelin and des-acyl ghrelin: two major forms of rat ghrelin peptide in gastrointestinal tissue. Biochem Biophys Res Commun 2000; 279: 909-913.
61. Dezaki K, Sone H, Koizumi M, et al. Blockade of pancreatic islet-derived ghrelin enhances insulin secretion to prevent high-fat diet-induced glucose intolerance. Diabetes 2006; 55: 3486-3493.
62. Zhang W, Chen M, Chen X, Segura BJ, Mulholland MW. Inhibition of pancreatic protein secretion by ghrelin in the rat. J Physiol 2001; 537: 231-236.
63. Kapica M, Laubitz D, Puzio I, Lubanska A, Zabielski R. The ghrelin pentapeptide inhibits the secretion of pancreatic juice in rats. J Physiol Pharmacol 2006; 54 Suppl. 3: 691-700.
64. Zhang V, Ren PG, Avsian-Kretchmer O, et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 2005; 310: 996-999.
65. McKee KK, Tan CP, Palyha OC, et al. Cloning and characterization of two human G protein-coupled receptor genes (GPR38 and GPR39) related to the growth hormone secretagogue and neurotensin receptors. Genomics 1997; 46: 426-434.
66. Lauwers E, Landuyt B, Arckens L, Schoofs L, Luyten W. Obestatin does not activate orphan G protein-coupled receptor GPR39. Biochem Biophys Res Commun 2006; 351: 21-25.
67. Holst B, Egerod KL, Schild E, et al. GPR39 signaling is stimulated by zinc ions but not by obestatin. Endocrinology 2007; 148: 13-20.
68. Chanoine JP, Wong AC, Barrios V. Obestatin, acylated and total ghrelin concentrations in the perinatal rat pancreas. Horm Res 2006; 66: 81-88.
69. Moechars D, Depoortere I, Moreaux B, et al. Altered gastrointestinal and metabolic function in the GPR39-obestatin receptor knockout mouse. Gastroenterology 2006; 131: 1131-1141.
70. Green BD, Irwin N, Flatt PR. Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice. Peptides 2007; 28: 981-987.
71. Stenström B, Furnes MW, Tommeras K, et al. Mechanism of gastric bypass-induced body weight loss: one-year follow-up after micro-gastric bypass in rats. J Gastrointest Surg 2006; 10: 1384-1391.
72. Zizzari P, Longchamps R, Epelbaum J, Bluet-Pajot MT. Obestatin partially affects ghrelin stimulation of food intake and GH secretion in rodents. Endocrinology 2007; 148: 1648-1653.
73. Dornonville de la Cour C, Björkqvist M, Sandvik AK, Bakke I, Zhao CM, Chen D, Hakanson R. A-like cells in the rat stomach contain ghrelin and do not operate under gastrin control. Regul Pept 2001; 99:141-150.
74. Furnes WM, Stenström B, Tommeras K, et al. Feeding behaviour in rats subjected to gastrectomy or gastric bypass surgery. Eur Surg Res 2008; 40: 279-288.
75. Kapica M, Zabielska M, Puzio I, et al. Obestatin stimulates the secretion of pancreatic juice enzymes through a vagal pathway in anaesthetized rats - preliminary results. J Physiol Pharmacol 2007; 58 Suppl 3: 123-130.
76. Tatemoto K, Hosoya M, Habata Y, et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 1998; 251: 471-476.
77. Habata Y, Fujii R, Hosoya M, et al. Apelin, the natural ligand of the orphan receptor APJ, is abundantly secreted in the colostrum. Biochim Biophys Acta 1999; 1452: 25-35.
78. O'Carroll AM, Selby TL, Palkovits M, Lolait SJ. Distribution of mRNA encoding B78/apj, the rat homologue of the human APJ receptor, and its endogenous ligand apelin in brain and peripheral tissues. Biochim Biophys Acta 2000; 1492: 72-80.
79. Boucher J, Masri B, Daviaud D, et al. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology 2005; 146: 1764-1771.
80. O'Shea M, Hansen MJ, Tatemoto K, Morris MJ. Inhibitory effect of apelin-12 on nocturnal food intake in the rat. Nutr Neurosci 2003; 6: 163-167.
81. Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M. Minireview: Ghrelin and the regulation of energy balance, a hypothalamic perspective. Endocrinology 2001; 142: 4163-4169.
82. Tschop M, Strasburger CJ, Topfer M, et al. Influence of hypobaric hypoxia on leptin levels in men. Int J Obes Relat Metab Disord 2000; 24 Suppl. 2: S151.
83. Garcia-Diaz D, Campioin J, Milagro FI, Martinez JA. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem 2007; 305: 87-94.
84. Wang G, Anini Y, Wei W, et al. Apelin, a new enteric peptide: localization in the gastrointestinal tract, ontogeny, and stimulation of gastric cell proliferation and of cholecystokinin secretion. Endocrinology 2004; 145: 1342-1348.
85. Susaki E, Wang G, Cao G, Wang HQ, Englander EW, Greeley GH Jr. Apelin cells in the rat stomach. Regul Pept 2005; 129: 37-41.
86. Sunter D, Hewson AK, Dickson SL. Intracerebroventricular injection of apelin-13 reduces food intake in the rat. Neurosci Lett 2003; 353: 1-4.
87. Medhurst AD, Jennings CA, Robbins MJ, et al. Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin. J Neurochem 2003; 84: 1162-1172.
88. Sörhede Winzell M, Ahrén B. The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes. Diabetes 2004; 53 Suppl. 3: S215-S219.
89. Ahrén B. Autonomic regulation of islet hormone secretion-implications for health and disease. Diabetologia 2000; 43: 393-410.
90. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 2000; 74: 34-41.
91. Kapica M, Jankowska A, Puzio I, Antushevich H, Zabielski R. Preliminary data on the role of apelin in controlling rat exocrine pancreas Pancreatology 2008; 8: 310.
92. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998; 95: 322-327.
93. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-585.
94. Korczyński W, Ceregrzyn M, Matyjek R, et al. Central and local (enteric) action of orexins. J Physiol Pharmacol 2006; 57: 17-42.
95. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998; 92: 573-585.
96. Dube MG, Kalra SP, Kalra PS. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 1999; 842: 473-477.
97. Lubkin M, Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 1998; 253: 241-245.
98. Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol 1999; 160: R7-12.
99. Yamada H, Okumura T, Motomura W, Kobayashi Y, Kohgo Y. Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem Biophys Res Commun 2000; 267: 527-531.
100. Haynes AC, Jackson B, Chapman H, et al. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept 2000; 96: 45-51.
101. Piper DC, Upton N, Smith MI, Hunter AJ. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur J Neurosci 2000; 12: 726-730.
102. Miyasaka K, Masuda M, Kanai S, Sato N, Kurosawa M, Funakoshi A. Central orexin-A stimulates pancreatic exocrine secretion via the vagus. Pancreas 2002; 25, Supl. 4: 400-404.
103. Grabauskas G, Moises HC. Gastrointestinal-projecting neurones in the dorsal motor nucleus of the vagus exhibit direct and viscerotopically organized sensitivity to orexin. J Physiol 2003; 549: 37-56.
104. Korczyński W, Ceregrzyn M, Kato I, Wolinski J, Zabielski R. The effect of orexins on intestinal motility in vitro in fed and fasted rats. J Physiol Pharmacol 2006; 57: 43-54.
105. Lopez M, Senaris R, Gallego R, et al. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology 1999; 140: 5991-5994.
106. Kirchgessner AL, Liu M. Orexin synthesis and response in the gut. Neuron 1999; 24: 941-951.
107. Yamanaka A, Kunii K, Nambu T, et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res 2000; 859: 404-409.
108. Irahara M, Tamura T, Matuzaki T, et al. Orexin-A suppresses the pulsatile secretion of luteinizing hormone via beta-endorphin. Biochem Biophys Res Commun 2001; 281: 232-236.
109. Kohsaka A, Watanobe H, Kakizaki Y, Suda T, Schioth HB. A significant participation of orexin-A, a potent orexigenic peptide, in the preovulatory luteinizing hormone and prolactin surges in the rat. Brain Res 2001; 898: 166-170.